Patents by Inventor Danielle Ianzer

Danielle Ianzer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROLINE-RICH PEPTIDES, PHARMACEUTICAL COMPOSITION, USE OF ONE OR MORE PEPTIDES AND METHOD OF TREATMENT
    Publication number: 20100035822
    Abstract: The present invention provides oligopeptides with amino acid sequences comprised in set forth in SEQ ID NO 1 to 18, capable of binding to diverse targets, generating increase and sustenance to nitric oxide (NO) production in mammalian cells, potentiate the argininosuccinate synthase activity of animal cells and/or increase the intracellular bivalent calcium ion in animal cells. Also disclosed are pharmaceutical compositions of one or more peptides described in the present invention. The invention further relates to the use of these peptides.
    Type: Application
    Filed: January 5, 2007
    Publication date: February 11, 2010
    Applicant: PEP FARMA CONSULTORIA E DESENVOLVIMENTO FARMACEUTI
    Inventors: Antônio Camargo, Danielle Ianzer, Carlos Silvia, Claudiana Gomes, Juliano Guerreiro
  • Pharmaceutical Compositions Preparation of Peptides, Secreted by the Snake Venom Glands, Particularly of Bothrops Jararaca, Vasopeptidases Inhibitors, Evasins, Their Analogues, Derivatives and Products Associated, Thereof, for Development of Applications and Use in Chronic-Degenerative Diseases
    Publication number: 20080199503
    Abstract: The present invention is characterized by the process of preparation of pharmaceutical compositions for the development of applications of the Evasins and their structural and/or conformational analogues in chronic-degenerative diseases. It is further characterized by the process of preparation of pharmaceutical compositions and related products of the Evasins peptides and their structural and/or conformational analogues in using the cyclodextrins, its derivatives, liposomes and biodegradable polymers and/or mixture of these systems. The invention is further characterized by the increased efficacy of these peptides and their analogues included in cyclodextrins, when administered to rats. This characterizes an increased biodisponibility of these peptides and their analogues using the compositions of the present invention.
    Type: Application
    Filed: December 9, 2003
    Publication date: August 21, 2008
    Applicant: Biolab Sanus Farmaceutica Ltd.
    Inventors: Antonio Camargo, Robson Santos, Ruben Millan, Danielle Ianzer, Mirian Hayashi
  • Isolation and purification procedure of vasopeptidase peptide inhibitors
    Publication number: 20050031604
    Abstract: The present invention patent refers to the isolation and purification of peptides secreted by serpent venom glands, specifically Bothrops jararaca; to the peptide thus obtained, as well as to the production procedures by genetic engineering techniques in procaryotic and eukaryotic systems; to the engineered peptide thus obtained; to the production of said peptide by chemical synthesis, as well as to the peptide resulting from this chemical processing. It also refers to the utilization of said peptides, obtained by different procedures, in distinct pharmaceutical compositions, and introduced into the organism by a variety of means, in order for them to act as inhibitors of vasopeptidases, and consequently reduce systemic arterial blood pressure, and show local vasodilating action.
    Type: Application
    Filed: March 18, 2002
    Publication date: February 10, 2005
    Inventors: Antonio Carlos de Camargo, Fernanda Calheta Portaro, Alessandra Murbach, Danielle Ianzer, Sandra Helena Farsky, Mario Palma, Mirian Furuie